Literature DB >> 14572777

Red wine prevents homocysteine-induced endothelial dysfunction in porcine coronary arteries.

Weiping Fu1, Brian S Conklin, Peter H Lin, Alan B Lumsden, Qizhi Yao, Changyi Chen.   

Abstract

BACKGROUND: Hyperhomocysteinemia is an independent risk factor of coronary artery disease. Clinical studies have indicated that moderate red wine consumption is associated with a reduction of incidence of coronary artery disease. In this study, we determined the effect of red wine on homocysteine- induced endothelial dysfunction in porcine coronary arteries.
MATERIALS AND METHODS: Porcine coronary arteries were dissected from 6 pig hearts and cut into 5-mm ring segments, which were assigned into 4 groups (9 rings/group): blank control, homocysteine treated (50 muM), red wine treated (0.08% alcohol), and homocysteine plus red wine treated. The rings were cultured in cell culture medium with or without treatment for 24 h. Myograph analysis was performed with U46619 (10(-7) M) for contraction and cumulative bradykinin (10(-9) to 10(-5) M) for endothelium-dependent relaxation. The endothelial nitric oxide synthase (eNOS) levels were analyzed by RT-PCR, Western blot, and immunohistochemistry.
RESULTS: In response to 10(-5) M bradykinin, porcine coronary artery rings treated with homocysteine (50 muM) showed a significant reduction of endothelium-dependent vasorelaxation by 43% as compared to controls (P < 0.05). However, rings treated with red wine (0.08% alcohol) plus homocysteine showed no significant difference as compared to controls. Endothelium-dependent vasorelaxation was not different between control and red wine treated groups. Furthermore, eNOS mRNA density levels were significantly reduced by 36% in homocysteine treated group as compared to controls (P < 0.05). eNOS protein levels were also substantially reduced in the homocysteine-treated group. However, red wine treatment reversed the effect of homocysteine-induced eNOS downregulation.
CONCLUSIONS: Homocysteine significantly impaired endothelial functions including endothelium-dependent vasorelaxation and eNOS mRNA and protein levels in porcine coronary arteries; and red wine effectively prevented homocysteine-induced endothelial dysfunction. This study suggests that protecting coronary endothelial cells from homocysteine damage may be an important mechanism of red wine for preventing coronary artery disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14572777     DOI: 10.1016/s0022-4804(03)00247-6

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  5 in total

1.  The polyphenol-rich extracts from black chokeberry and grape seeds impair changes in the platelet adhesion and aggregation induced by a model of hyperhomocysteinemia.

Authors:  Joanna Malinowska; Wieslaw Oleszek; Anna Stochmal; Beata Olas
Journal:  Eur J Nutr       Date:  2012-07-19       Impact factor: 5.614

2.  Endothelial nitric oxide synthase gene variants and primary open-angle glaucoma: interactions with hypertension, alcohol intake, and cigarette smoking.

Authors:  Jae Hee Kang; Janey L Wiggs; Bernard A Rosner; Jonathan Haines; Wael Abdrabou; Louis R Pasquale
Journal:  Arch Ophthalmol       Date:  2011-06

3.  Effects of red grape juice consumption on high density lipoprotein-cholesterol, apolipoprotein AI, apolipoprotein B and homocysteine in healthy human volunteers.

Authors:  Mohammad H Khadem-Ansari; Yousef Rasmi; Fatemeh Ramezani
Journal:  Open Biochem J       Date:  2010-12-15

4.  Ginsenoside Rb1 preconditioning enhances eNOS expression and attenuates myocardial ischemia/reperfusion injury in diabetic rats.

Authors:  Rui Xia; Bo Zhao; Yang Wu; Jia-Bao Hou; Li Zhang; Jin-Jin Xu; Zhong-Yuan Xia
Journal:  J Biomed Biotechnol       Date:  2011-10-16

Review 5.  Wine, beer, alcohol and polyphenols on cardiovascular disease and cancer.

Authors:  Sara Arranz; Gemma Chiva-Blanch; Palmira Valderas-Martínez; Alex Medina-Remón; Rosa M Lamuela-Raventós; Ramón Estruch
Journal:  Nutrients       Date:  2012-07-10       Impact factor: 6.706

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.